Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CORDIALLY® - CEE: Characteristics of Patients With Type 2 Diabetes Treated With Modern Antidiabetic Drugs. A Real World Data Collection of Patient Baseline Characteristics, Treatment Patterns and Comorbidities in Central Eastern European (CEE) Countries

NCT03807440 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03807440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CORDIALLY® - CEE: Characteristics of Patients With Type 2 Diabetes Treated With Modern Antidiabetic Drugs. A Real World Data Collection of Patient Baseline Characteristics, Treatment Patterns and Comorbidities in Central Eastern European (CEE) Countries
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
August 26, 2019
Completion date
August 31, 2021
Enrollment
4,083 (actual)
Sites
177

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2